You are here: Welcome » Anuradha Poonepalli

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
anuradha_poonepalli [2023/03/12 02:43]
liam
anuradha_poonepalli [2023/03/12 03:31] (current)
liam
Line 3: Line 3:
 {{ ::anuradha_poonepalli.png?200|}} {{ ::anuradha_poonepalli.png?200|}}
  
-Dr. **Anuradha Poonepalli** is a pharmaceutical regulatory specialist based in [[Singapore]].+Dr. **Anuradha Poonepalli** is a pharmaceutical regulatory specialist based in [[Singapore]]. She is a consultant in the Health Products Regulation Group of the [[Health Sciences Authority]] (HSA).((Jasarevic, T. (2020, April 13). //Public statement for collaboration on COVID-19 vaccine development.// World Health Organization. http://archive.today/2020.10.04-153106/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development)) 
 + 
 +===== History ===== 
 + 
 +==== Pandemic Preparedness ==== 
 + 
 +{{ ::27164308_1675020739224181_2721031257246487712_o.jpg?200|}} 
 + 
 +On January 29-30, 2018, Poonepalli participated as a speaker in a conference titled "DIA and CoRE Conference 2018: Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases", hosted by the [[Drug Information Association]] (DIA) and the [[Duke-NUS Centre of Regulatory Excellence]] (CoRE).((//DIA and CoRE Conference 2018: Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases.// Duke-NuS Medical School. Retrieved August 11, 2018, from http://archive.today/2018.08.11-154129/https://www.duke-nus.edu.sg/core/event/dia-and-core-conference-2018-accelerating-access-innovative-products-%E2%80%93-improving-responses)) 
 + 
 +==== COVID-19 ==== 
 + 
 +Poonepalli participated in a February 11-12, 2020 event titled "2019 novel Coronavirus Global research and innovation forum: towards a research roadmap" co-hosted by the [[World Health Organization]] [[R&D Blueprint]] and [[Global Research Collaboration for Infectious Disease Preparedness]] (GLOPID-R). She and [[Philip Krause]] presented on the topic of "Candidate vaccines R&D".((//2019 novel Coronavirus Global research and innovation forum: towards a research roadmap AGENDA.// (2020). GLOPID-R. https://web.archive.org/web/20230208185417/https://www.glopid-r.org/wp-content/uploads/2020/02/covid-19-global-research-and-innovation-forum-2020-program.pdf)) 
 + 
 +She was announced as a member of the [[Ministry of Health of Singapore]]'s Expert Committee on COVID-19 Vaccination on November 13, 2020.((kathleen. (2020, November 13). //MOH appoints expert committee to make recommendations for S’pore’s COVID-19 vaccination strategy.// The Online Citizen Asia. http://archive.today/2023.03.12-022741/https://www.theonlinecitizen.com/2020/11/13/moh-appoints-expert-committee-to-make-recommendations-for-spores-covid-19-vaccination-strategy/?amp)) ((Cheong, D., Yang, W., Prof, A., Yin, C., Gascoigne, N., Lim, P., Lian, P., Hospital, S., Lye, D., & Chee, R. //Composition of the Expert Committee on COVID-19 Vaccination.// Ministry of Health. Retrieved March 12, 2023, from https://web.archive.org/web/20221101061806/https://www.moh.gov.sg/docs/librariesprovider5/pressroom/press-releases/annex-expert-comm-rev.pdf))
  
 ===== External links ===== ===== External links =====
  
   * [[https://www.linkedin.com/in/dr-anuradha-poonepalli-57174715/|LinkedIn]]   * [[https://www.linkedin.com/in/dr-anuradha-poonepalli-57174715/|LinkedIn]]
Back to top